ISOPP CAPhO 2025 Symposium: Tackling TKI-IO Toxicities Together: A Fireside Chat on aRCC Treatment - Ipsen Biopharmaceuticals Canada On-Demand Symposium

Join us for Tackling TKI Toxicities Together: A Fireside Chat on Advanced RCC Treatment, an on-demand symposium focused on managing adverse events associated with TKI therapy in advanced RCC. Expert panelists, including an oncologist, pharmacist, and a patient, will dive into the challenges of TKI-related toxicities, offering strategies for effective management. Attendees will gain insights into the patient and pharmacist's role in improving patient adherence, including the importance of dose individualization and monitoring for optimal outcomes. Through a real-life example and an interactive fireside chat, participants will leave with practical tips for enhancing TKI therapy management in aRCC care.

Learning Objectives:

1. Understand Overlapping Toxicities of IO/TKI Combinations: Learn about the toxicities from combining IO therapies and TKIs in RCC treatment and strategies for managing them.
2. Enhance the Pharmacist’s Role in Access and Adherence: Explore how pharmacists ensure patient access to therapies and support adherence through education and management.
3. Implement Dose Individualization and Monitoring: Develop skills in dose adjustments and monitoring to optimize outcomes, focusing on managing side effects and differences between IO therapies and TKIs.